Using a latent class model to refine risk stratification in multiple myeloma
Authors:
- 17 June 2015
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 34 (21) , 2971-2980
Abstract
In multiple myeloma research, the GEP70 model is known to be capable of predicting a high risk patient group for disease progression based on the expression levels of 70 selected genes measured at baseline. The model consists of a continuous gene score that is a linear combination of the 70 genes along with a cutoff, such that patients with a score greater than the cutoff are categorized as high risk and otherwise low risk for disease progression. However, the continuous gene score may be confusing at times because of its open range nature. In addition, the present two-group model is sensitive to scores falling close to its cutoff. To facilitate patients' understanding of their prognosis, it is desirable to convert the continuous score into a probability that has an easier interpretation. In this article, we employ a latent class model to address this issue, and we also propose a superior grey zone model to refine the current risk stratification associated with the GEP70 model. Lastly, we demonstrate the robustness of the grey zone model with results from a simulation study. Copyright © 2015 John Wiley & Sons, Ltd.Keywords
This publication has 15 references indexed in Scilit:
- The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myelomaInternational Journal of Hematology, 2011
- Superior results of Total Therapy 3 (2003-33) in gene expression profiling–defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenanceBlood, 2010
- Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3British Journal of Haematology, 2007
- Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular geneticsBritish Journal of Haematology, 2007
- A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1Blood, 2006
- Thalidomide and Hematopoietic-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2006
- Explained randomness in proportional hazards modelsStatistics in Medicine, 2004
- A. R.2type measure of dependence for proportional hazards modelsJournal of Nonparametric Statistics, 1999
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958